As regards as, the LPS challenge is widely used as an experimental model of AMD, involving the activation of Toll-like receptor 4 (TLR-4) and the downstream activation of NFκB (Sung et al., 2019; Hikage et al., 2021), and then triggering the expression of inflammatory cytokines. Here, TLR4 is linked to age-related macular degeneration.